G L Shu

1.9k citations
17 papers · 1.7k indexed · h-index 15
Topics
T-cell and B-cell Immunology (12 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)Immunotherapy and Immune Responses (7 papers)

In The Last Decade

G L Shu

17 papers receiving 1.7k citations

Peers

G L Shu
Comparison fields: 5 of 73
  • Immunology 1.3k
  • Radiology, Nuclear Medicine and Imaging 354
  • Molecular Biology 346
  • Cancer Research 288
  • Oncology 275
Replace L Strockbine with:
L Strockbine United States
Frederick W. Alt United States
Sidorenko Sp Ukraine
John S. Wotherspoon Australia
HJ Gruss Germany
Ulrich Krawinkel Germany
Toine ten Broeke Netherlands
Yong-Jun Liu China
A Rolink Switzerland
Juanita Campos-Torres United States
G L Shu relative to L Strockbine United States L Strockbine's profile →
Citations per field
00.5×1.5×1.9×
L Strockbine · 1×
Citations per year

Countries citing papers authored by G L Shu

Since Specialization
Citations

This map shows the geographic impact of G L Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G L Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G L Shu more than expected).

Fields of papers citing papers by G L Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G L Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G L Shu. The network helps show where G L Shu may publish in the future.

Co-authorship network of co-authors of G L Shu

This figure shows the co-authorship network connecting the top 25 collaborators of G L Shu. A scholar is included among the top collaborators of G L Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G L Shu. G L Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 2
2 32
3 164
4 29
5 319
6 82
7 87
8 291
9 23
10 160
11 80
12 81
13 39
14 123
15 58
16 154
17 1

About G L Shu

G L Shu is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 17 papers that have together received 1.7k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (12 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immunotherapy and Immune Responses (7 papers). The work is most often cited by research in Immunology (1.3k citations), Immunology and Allergy (176 citations) and Cancer Research (288 citations). G L Shu has collaborated with scholars based in United States, Germany and South Africa. Frequent co-authors include Edward A. Clark, Ingolf Berberich, J A Ledbetter, Bo Dupont, Lydia Koulova, Thomas B. Barrett, Michael P. Gallagher, Mary A. Valentine, J A Ledbetter and K H Grabstein. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026